Guidance
Interesting shortcuts
EFFRA Members' Perspectives
News Dashboard
Structured Wiki
Search
FoF and Made in Europe Partnership
Demonstrators, pilots, prototypes
Exploitable result(s)
Significant innovations and lessons learned, training aspects
Report - Video - Presentation - Publication....?
Project clusters
Company perspectives
Manufacturing future products
Manufacturing performance characteristics
Technologies and enablers
ICT performance characteristics
Standards, technical committees and working groups
Contribution of R&I projects to standardisation
Regulatory and policy aspects
Standards - other classifications
Business model aspects
Pathways
MiE SRIA R&I Priorities
MiE WP26-27 Consultation - Potential Research Topics only
MiE WP26-27 Consultation and context pointers
MiE WP26-27 Consultation with pointers to WP25-27 consultation
MiE KPIs
Relevant (future) calls
EU-Programme-Call
NACE code
EFFRA Organisations - members
EFFRA WG pointers
Pathways
Pathways
Projects
Projects
Resources
Resources
Project ideas
Project ideas
People & organisations
People
Organisations
portal@effra.eu
Visit the EFFRA website
Login
Structured Wiki
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.0. Cross-cutting call topics
H2020-EU.3.1.0. Cross-cutting call topics
H2020-Adhoc-2014-20
Health Health
H2020-HCO-2014
HCO-14-2014 Bridging the divide in European health research and innovation
HCO-15-2014 Mobilisation and mutual learning action plan
HCO-16-2014 National contact points
H2020-IBA-SC1-BIOMEDICAL-2017
IBA-SC1-BIOMEDICAL-2017
H2020-IBA-SC1-CORONAVIRUS-2020-4
IBA-SC1-CORONAVIRUS-2020-4 EU-wide Covid-19 vaccine trial network
H2020-IBA-SC1-eHealth-2017
IBA-SC1-eHealth-2017
H2020-IBA-SC1-Presidency-2020
IBA-SC1-Presidency-2020
H2020-JTI-IMI2-2015-08-single-stage
IMI2-2015-08-01 Ebola and other filoviral haemorrhagic fevers (Ebola+) programme: future outbreaks
H2020-JTI-IMI2-2020-20-two-stage
IMI2-2020-20-01 Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis
IMI2-2020-20-02 Innovations to accelerate vaccine development vaccine development and manufacture
IMI2-2020-20-03 Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
IMI2-2020-20-04 Tumour plasticity
IMI2-2020-20-05 Proton versus photon therapy for oesophageal cancer - a trimodality strategy
IMI2-2020-20-06 Handling of protein drug products and stability concerns
H2020-JTI-IMI2-2020-22-single-stage
IMI2-2020-22-01 Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities
SC1-BHC-37-2020 Towards the new generation of clinical trials ? trials methodology research
H2020-JTI-IMI2-2020-23-two-stage
IMI2-2020-23-01 Returning Clinical Trial Data to study participants within a GDPR compliant and approved ethical framework
IMI2-2020-23-02 Modelling the impact of monoclonal antibodies and vaccines on the reduction of antimicrobial resistance
IMI2-2020-23-03 A platform for accelerating biomarker discovery and validation to support therapeutics development for neurodegenerative diseases
IMI2-2020-23-04 Optimal treatment for patients with solid tumours in Europe through Artificial Intelligence
IMI2-2020-23-05 Shortening the path to Rare Disease diagnosis by using newborn genetic screening and digital technologies
IMI2-2020-23-06 Behavioural Model of Factors Affecting Patient Adherence
H2020-PHC-2014-single-stage
PHC-20-2014 Advancing active and healthy ageing with ICT: ICT solutions for independent living with cognitive impairment
PHC-26-2014 Self management of health and disease: citizen engagement and mHealth
H2020-SC1-2020-Single-Stage-RTD
SC1-BHC-06-2020 Digital diagnostics ? developing tools for supporting clinical decisions by integrating various diagnostic data
SC1-BHC-11-2020 Advancing the safety assessment of chemicals without the use of animal testing
SC1-BHC-17-2020 Global Alliance for Chronic Diseases (GACD) - Prevention and/or early diagnosis of cancer
SC1-BHC-20A-2020 Pre-commercial procurement (PCP) for integrated care solutions
SC1-BHC-33-2020 Addressing low vaccine uptake
SC1-BHC-34-2020 New approaches for clinical management and prevention of resistant bacterial infections in high prevalence settings
SC1-BHC-35-2020 Creation of a European wide sustainable network for harmonised large-scale clinical research studies for infectious diseases
SC1-BHC-36-2020 Micro- and nano-plastics in our environment: Understanding exposures and impacts on human health
SC1-DTH-12-2020 Use of Real-World Data to advance research on the management of complex chronic conditions
SC1-HCC-10-2020 Towards a Health research and innovation Cloud: Capitalising on data sharing initiatives in health research
SC1-HCO-03-2020 Bridging the divide in health research and innovation ? boosting return on investment
SC1-HCO-07-2020 ERA-NET to support the Joint Programming Initiative on Antimicrobial resistance (JPIAMR)
SC1-HCO-14-2020 ERA-NET: Sustained collaboration of national and regional programmes in cancer research
SC1-HCO-16-2020 ERA-NET: Sustained collaboration of national and regional programmes in research on brain-related diseases and disorders of the nervous system
SC1-HCO-17-2020 Coordinating and supporting research on the human microbiome in Europe and beyond
SC1-HCO-18-2020 Developing methodological approaches for improved clinical investigation and evaluation of high-risk medical devices
SC1-HCO-19-2020 Reliable and accessible information on cell and gene-based therapies
SC1-HCO-20-2020 Coordination of clinical research activities of the European Reference Networks
SGA-SC1-CEPI-2020 Grant to the Coalition for Epidemic Preparedness Innovations (CEPI)
H2020-SC1-2020-Two-Stage-RTD
SC1-BHC-24-2020 Healthcare interventions for the management of the elderly multimorbid patient
SC1-BHC-24-2020 Healthcare interventions for the management of the elderly multimorbid patient
SC1-BHC-29-2020 Innovative actions for improving urban health and wellbeing - addressing environment, climate and socioeconomic factors
SC1-DTH-13-2020 Implementation research for scaling up and transfer of innovative solutions involving digital tools for people-centred care
SC1-DTH-13-2020 Implementation research for scaling up and transfer of innovative solutions involving digital tools for people-centred care
H2020-SC1-DTH-2020-1
SC1-DTH-02-2020 Personalised early risk prediction, prevention and intervention based on Artificial Intelligence and Big Data technologies
SC1-DTH-04-2020 International cooperation in smart living environments for ageing people
SC1-DTH-06-2020 Accelerating the uptake of computer simulations for testing medicines and medical devices
SC1-DTH-14-2020 Pre-commercial Procurement for Digital Health and Care Solutions
SC1-HCC-08-2020 Scaling up innovation for active and healthy ageing
SC1-HCC-09-2020 Supporting deployment of eHealth in low and lower middle income countries in Africa for better health outcomes
H2020-SC1-FA-DTS-2020-1
DT-TDS-04-2020 AI for Genomics and Personalised Medicine
H2020-SC1-PHE-CORONAVIRUS-2020-2-CNECT
SC1-PHE-CORONAVIRUS-2020-2B
H2020-SC1-PHE-CORONAVIRUS-2020-2-RTD
SC1-BHC-08-2020 New interventions for Non-Communicable Diseases
SC1-PHE-CORONAVIRUS-2020-2C Behavioural, social and economic impacts of the outbreak response
SC1-PHE-CORONAVIRUS-2020-2D Pan-European COVID-19 cohorts
SC1-PHE-CORONAVIRUS-2020-2E Networking of existing EU and international cohorts of relevance to COVID-19
H2020-SMEINST-1-2014
PHC-12-2014-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices
H2020-SMEINST-2-2014
PHC-12-2014 Clinical research for the validation of biomarkers and/or diagnostic medical devices
H2020-SMEINST-2-2015
PHC-12-2015 Clinical research for the validation of biomarkers and/or diagnostic medical devices
H2020-SMEINST-2-2016-2017
SMEInst-05-2016-2017 Supporting innovative SMEs in the healthcare biotechnology sector